V017-3797 Screening compound: 1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-[2-(piperidin-1-yl)ethyl]piperidine-4-carboxamide

V017-3797 Screening compound: 1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-[2-(piperidin-1-yl)ethyl]piperidine-4-carboxamide
V017-3797 Screening compound: 1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-[2-(piperidin-1-yl)ethyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V017-3797
1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-[2-(piperidin-1-yl)ethyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V017-3797

Molecular Formula

C27H41N5O (C27 H41 N5 O)

Compound Name

1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-[2-(piperidin-1-yl)ethyl]piperidine-4-carboxamide

IUPAC name

1-[1-(cyclohexylmethyl)-1H-13-benzodiazol-2-yl]-N-[2-(piperidin-1-yl)ethyl]piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1c1nc(cccc2)c2n1CC1CCCCC1)NCCN1CCCCC1

InChI

InChI=1S/C27H41N5O/c33-26(28-15-20-30-16-7-2-8-17-30)23-13-18-31(19-14-23)27-29-24-11-5-6-12-25(24)32(27)21-22-9-3-1-4-10-22/h5-6,11-12,22-23H,1-4,7-10,13-21H2,(H,28,33)

InChI Key

RPWDSHGMBWVVLT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19968699

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

451.66

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.091

Distribution Coefficient, logD

3.283

Water Solubility, LogSw

-5.01

Polar Surface Area

41.590

Acid Dissociation Constant (pKa)

13.35

Base Dissociation Constant (pKb)

9.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

70.40

V017-3797 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V017-3797 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V017-3797?
Check Price and Availability of V017-3797, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V017-3797 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V017-3797
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V017-3797
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V017-3797 available by request